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Role of 2-5A-dependent RNase-L in senescence and longevity
JB Andersen , XL L , CS Judge , A Zhou , BK Jha , S Shelby , L Zhou , RH Silverman
and BA Hassel
Senescence is a permanent growth arrest that restricts
the lifespan of primary cells in culture, and represents an
in vitro model for aging. Senescence functions as a tumor
suppressor mechanism that can be induced independent of
replicative crisis by diverse stress stimuli. RNase-L
mediates antiproliferative activities and functions as a
tumor suppressor in prostate cancer, therefore, we
examined a role for RNase-L in cellular senescence and
aging. Ectopic expression of RNase-L induced a senescent
morphology, a decrease in DNA synthesis, an increase in
senescence-associated b-galactosidase activity, and accel-
erated replicative senescence. In contrast, senescence was
retarded in RNase-L-null fibroblasts compared with wild-
type fibroblasts. Activation of endogenous RNase-L by
2-5A transfection induced distinct senescent and apoptotic
responses in parental and Simian virus 40-transformed
WI38 fibroblasts, respectively, demonstrating cell type
specific differences in the antiproliferative response to
RNase-L activation. Replicative senescence is a model for
in vivo aging; therefore, genetic disruption of senescence
effectors may impact lifespan. RNase-L / mice survived
31.7% (Po0.0001) longer than strain-matched RNase-
L+/+ mice providing evidence for a physiological role for
RNase-L in aging. These findings identify a novel role for
RNase-L in senescence that may contribute to its tumor
suppressive function and to the enhanced longevity of
RNase-L / mice.
Keywords: RNase-L; senescence; apoptosis; 20-50-oligo-
adenylate; aging
Introduction
Eukaryotic cells have evolved mechanisms that block
proliferation in response to genetic and epigenetic
insults via growth arrest or cell death. These responses
serve a common function, to prevent the introduction of
potentially oncogenic mutations into the host genome,
but exhibit distinct phenotypes including quiescence,
senescence and apoptosis (Schmitt, 2003). Growth arrest
can be either transient, in which quiescent cells retain the
capacity to re-enter the cell cycle upon mitogenic
stimulation, or permanent, in which cells enter a post-
replicative but metabolically active state known as
senescence. Senescence is a mechanism that restricts
the replicative lifespan of primary cells in culture via
telomere shortening, and represents an in vitro model for
organismal aging (Hayflick, 1965) and reviewed by
Campisi (2003) and Shay and Roninson (2004). Pre-
mature senescence can also be induced independent of
replicative crisis by stimuli including DNA damage,
oncogene expression and cell stress (Schmitt, 2003; Shay
and Roninson, 2004). In contrast to quiescence and
senescence in which cells remain viable, apoptosis results
from the activation of genetically programmed catabolic
pathways that lead to cell death. Importantly, identical
insults can result in apoptosis or senescence depending
on the cellular context (Schmitt, 2003; Shay and
Roninson, 2004); this differential response may permit
the development of therapeutic agents to selectively
activate tumor-specific antiproliferative pathways.
Escape from constraints on cellular proliferation is a
requisite step in malignant transformation; accordingly,
apoptosis and senescence serve critical tumor suppressor
functions. Although the antitumor function of apoptosis
is well established, and has been exploited in therapeutic
regimens, the role of senescence as a tumor suppressive
mechanism in vivo has only recently been demonstrated.
Specifically, studies in four independent systems deter-
mined that senescent cells were increased in premalig-
nant lesions induced by oncogene activation, but were
absent from malignant tumors that had escaped this
proliferative block (Braig et al., 2005; Chen et al., 2005;
Collado et al., 2005; Michaloglou et al., 2005).
Consistent with a role for senescence in tumor suppres-
sion, the well-established tumor suppressors, p53 and
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RB, and their upstream regulators (e.g. p16INK4a/p19ARF)
and downstream effectors (e.g. p21CIP, E2F) were
identified as critical senescence mediators (Campisi,
2003). However, distinct profiles of gene expression are
associated with senescence induced by different stimuli,
and in specific cell types (Shelton et al., 1999; Yoon
et al., 2004; Collado et al., 2005; Hardy et al., 2005),
pointing out the need to better define the molecular
components of the senescence response in specific
physiological contexts.
Cytokines and growth factors function to maintain a
balance between cell proliferation and growth arrest or
apoptosis. Type 1 interferons (IFNa/b) were discovered
as antiviral cytokines, that also induce potent anti-
proliferative and immunomodulatory activities. IFN
induces a set of IFN-stimulated genes (ISGs) that
mediate its biological activities (Stark et al., 1998). The
2-5A-dependent RNase-L pathway is among the best-
characterized mediators of IFN action, and is comprised
of two primary enzymatic activities (Silverman, 2003). A
family of 20-50-oligoadenylate synthetases (OAS) are
induced by IFN and, when activated by double-stranded
RNA, polymerize adenosine triphosphate into, 20-50
linked, oligoadenylates (2-5A). 2-5A induces the dimeri-
zation and activation of a latent endoribonuclease,
RNase-L, which cleaves single-stranded viral, messenger
and ribosomal RNAs. RNase-L activity is attenuated
by proteasomal degradation (Chase et al., 2003),
2-5A inactivation by cellular phosphatases and a
20phosphodiesterase (Kubota et al., 2004), and by an
RNase-L inhibitor, RLI (Bisbal et al., 1995). Experi-
mental modulation of RNase-L expression and activity
has confirmed its role in the antiviral, antiproliferative
and proapoptotic activities of IFN (Hassel et al., 1993;
Castelli et al., 1997; Zhou et al., 1997). RNase-L also
exhibits antiproliferative effects independent of IFN,
suggesting that it serves a broader role as a natural
constraint on cell proliferation (Castelli et al., 1997;
Zhou et al., 1997). Consistent with this prediction, a
tumor suppressor function for RNase-L was recently
discovered by mapping of the hereditary prostate
cancer-1 susceptibility allele (HPC1) to the RNASE-L
gene locus (Carpten et al., 2002), and by the association
of RNase-L mutations with the disease (Casey et al.,
2002).
Recent efforts to identify senescence associated genes
have determined that the upregulation of several ISGs,
including the RNase-L activating enzyme, OAS, corre-
lates with the induction of a senescent phenotype,
whereas ISG repression is associated with cellular
immortalization (Shou et al., 2002; Untergasser et al.,
2002; Leszczyniecka et al., 2003; Yoon et al., 2004).
These findings suggested a role for ISGs in cellular
senescence, however the functional involvement in
senescence has been demonstrated for only a few specific
ISGs (e.g. IFI16 (Xin et al., 2004)). In light of the
established antiproliferative activities of RNase-L and
its role as a tumor suppressor, we investigated the
possible involvement of RNase-L in cellular senescence.
RNase-L expression or activation induced a senescent
phenotype in human diploid fibroblasts (HDFs)
whereas senescence was retarded in the absence of
RNase-L. Moreover, activation of RNase-L by exo-
genous 2-5A resulted in distinct senescent and apoptotic
responses in primary and immortalized HDFs, respec-
tively, indicating that cellular factors can dictate the
antiproliferative phenotype induced by RNase-L
activation. Interestingly, RNase-L / mice exhibited
a significantly extended lifespan as compared to strain-
matched RNase-Lþ /þ mice. These findings identify
RNase-L as a novel regulator of the senescence response
that impacts longevity in mice.
Results
Ectopic expression of RNase-L results in reduced
DNA synthesis
RNase-L functions in diverse antiproliferative processes
associated with IFN action (Hassel et al., 1993),
differentiation (Bisbal et al., 2000) and apoptosis
(Castelli et al., 1997; Zhou et al., 1997). To characterize
the antiproliferative activity of RNase-L in the absence
of exogenous agents, an RNase-L expression construct
was microinjected into subconfluent Balb-c 3T3 cells.
DNA synthesis was monitored by [3H]-thymidine
incorporation and autoradiography, and RNase-L
expression was detected by immunostaining with anti-
sera specific for the transgene-encoded protein. Cells
were not synchronized before microinjection and [3H]-
thymidine addition; accordingly, both labeled and
unlabeled nuclei were observed, indicative of the
proportion of cells that traversed S phase during the
course of the labeling. RNase-L expression was hetero-
geneous in the injected cells at the post-injection time
examined, which may reflect an influence of cell cycle on
its expression. Analysis of nuclear labeling and RNase-L
expression in the same cells by bright field and
fluorescence microscopy, revealed that RNase-L-expres-
sing cells did not display nuclear labeling, suggesting
that ectopic expression of RNase-L inhibited proli-
feration. In contrast, the nuclei of cells with low,
background staining for RNase-L expression were
strongly labeled (see arrowheads in Figure 1a). Control,
Figure 1 Ectopic expression of RNase L induces a senescent
phenotype. (a) Microinjection of an RNase L expression plasmid
reduces mitotic index. Balb c 3T3 cells were injected with plasmids
as indicated, and labeled with [3H] thymidine at 24 h post injection.
Cells were then fixed for RNase L immunostaining, and auto
radiography. Top and bottom panels are identical microscope
fields viewed in fluorescence and bright light, and are representative
of fields analysed in duplicate samples; note the lack of nuclear
labeling in cells expressing RNase L (indicated by arrows). (b)
Induction of RNase L results in a senescent morphology. Light
micrographs of NIH 3T3 cells stably transfected with IPTG
inducible RNase L or vector control cells 24 h after IPTG
induction; N, nucleus; C, cytoplasm; V, vacuole.
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vector-injected cells exhibited a higher frequency of
nuclear labeling. Thus, ectopic expression of RNase-L
resulted in a reduction in cells undergoing DNA
synthesis, a property that is characteristic of quiescent
and senescent cells.
RNase-L expression induces a senescent phenotype
The antiproliferative properties of RNase-L precluded
the generation of cell lines that stably express trans-
fected RNase-L, and transient transfections yield a
heterogeneous population of cells with respect to
RNase-L expression, thus limiting the analysis of its
biological activities. Therefore, we utilized NIH-3T3
cells stably transfected with an isopropyl b-D-thiogalac-
topyranoside (IPTG)-inducible RNase-L expression
construct to examine the effects of sustained RNase-L
expression. As previously reported, IPTG treatment
resulted in the induction of RNase-L protein within
24 h, and RNase-L expression induced apoptosis in the
majority of cells (Castelli et al., 1997). However, in a
subpopulation of cells, RNase-L induction resulted in a
senescent phenotype. Specifically, these cells exhibited
an increased cytoplasmic:nuclear volume and vacuoliza-
tion, and a flattened, multinucleate morphology. In
contrast, the mock induced cells retained a spindle
shaped, fibroblast morphology (Figure 1b). These
findings provide the first evidence of a link between
RNase-L and a senescent phenotype.
RNase-L induces senescence and reduces in vitro
proliferative lifespan
Senescence was first described as a mechanism that
limits the replicative capacity of primary cells in
culture (Hayflick, 1965); therefore, we determined the
effect of RNase-L expression on the proliferative
properties of HDFs that exhibit a finite proliferative
lifespan. RNase-L was stably introduced into early
passage parental WI38, and Simian virus 40 (SV40)-
immortalized SV-WI38, HDFs by retroviral transduc-
tion. Expression of the myc-tagged RNase-L transgene
was readily detected in the transduced cells, and, in
contrast to cell lines examined to date (Diaz et al.,
1997; Malathi et al., 2004), stable RNase-L expression
in WI38 HDFs did not induce apoptosis (not shown
and see Figure 4). To determine if RNase-L expression
altered the replicative lifespan of the cells, RNase-L-
transduced and vector control cells were passaged
at a constant inoculum, and the population doubling
level (PDL) was calculated at each passage. Cells
were considered senescent when they failed to double
in 2 weeks. When the population doubling time of the
RNase-L-transduced WI38 HDFs began to decline
(PDL 15), cells were stained for senescence-associated
b-galactosidase (b-gal) activity. Counting of the
stained cells revealed that 62% of RNase-L-transduced
WI38 HDFs were b-gal positive as compared to
only 18% in the vector control cells. In contrast, no
b-gal staining was observed in either the RNase-L-
or vector-transduced SV-WI38 cells (Figure 2a).
To address the possibility that RNase-L may induce
b-gal expression independent of senescence, we deter-
mined the consequences of RNase-L expression on
the in vitro proliferative lifespan of WI38 cells.
Replicative senescence was accelerated by nearly 3
weeks in the RNase-L WI38 as compared to vector
control cells (Figure 2b). The vector control cells
senesced at PDL B20 similar to the parental WI38
cells. Thus, ectopic expression of RNase-L markedly
reduced the lifespan of WI38 HDFs suggesting that it
serves a functional role in senescence; however, RNase-
L expression did not result in an antiproliferative
stimulus that was sufficient to induce senescence in
immortalized SV-WI38 cells.
Senescence is delayed in RNase-L-deficient fibroblasts
To examine the relationship between endogenous
RNase-L and senescence, we utilized embryonic fibro-
blasts derived from mice with a targeted disruption of
the RNase-L gene (Zhou et al., 1997). Mouse embryonic
fibroblasts (MEFs) undergo senescence at a much earlier
PDL than primary HDFs, accordingly, wild-type (WT)
and RNase-L / MEFs were analysed for b-gal positive
senescent cells after 10 population doublings (Figure 3).
Cell counts from three independent cultures revealed
that, at the same passage, 92% of the WT MEFs
exhibited b-gal staining, whereas only 27% of the
RNase-L / cells were b-gal positive (Figure 3a). The
RNase-L / MEFs continued to proliferate for two to
three additional passages after the WT cells had
senesced (Figure 3b). These findings indicate that the
absence of a functional RNase-L protein retards the
onset of senescence.
Figure 2 Ectopic expression of RNase L induces senescence
associated b gal activity and reduces replicative lifespan.
(a) WI38 derived cells were stained for b gal activity when the
WI38 RNase L cells began to exhibit proliferative arrest
(PDL 15). b gal positive cells were counted in 10 fields of
replicate cultures to quantify staining. (b) Cells were counted at
each passage, and the cumulative PDL was calculated. The curves
for the cumulative population doublings of WI38 SV40 pBABE
and WI38 SV40 RNase L coincide in the graph.
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RNase-L activation induces premature senescence
Ectopic RNase-L expression induced distinct responses
of senescence in HDFs (Figure 2) and apoptosis in
established cell lines (Castelli et al., 1997) that may
reflect a fundamental difference in the response of
primary and immortalized cells to antiproliferative
stimuli. To determine if RNase-L activation by exo-
genous 2-5A induced senescence in primary HDFs, and
if this response differed in SV40-immortalized cells in
which the critical senescence mediators p53 and pRb
are inactivated (White and Khalili, 2004), 2-5A was
transfected into parental and SV-WI38 cells. Remark-
ably, 2-5A transfection of primary WI38 HDFs induced
a dose-dependent, eightfold increase in b-gal staining
(Figure 4a and b), indicating that primary HDFs remain
viable, albeit senescent, following RNase-L activation.
In contrast, SV-WI38 cells displayed a high basal
level of senescent cells consistent with recent reports
of elevated senescence in premalignant cells (Braig
et al., 2005; Chen et al., 2005; Collado et al., 2005;
Michaloglou et al., 2005); however, 2-5A transfection
resulted in only a twofold increase in senescent cells
(Figure 4a, right panel). To determine if the reduction in
2-5A-induced senescence in SV-WI38 as compared to
WI38 cells reflected a distinct, apoptotic response, we
analysed the induction of apoptosis following 2-5A
transfection by TdT-mediated dNTP nick end labeling
(TUNEL) assay. Interestingly, no TUNEL-positive
cells were detected in 2-5A-transfected WI38 cells,
whereas SV-WI38 cells displayed a significant increase
in apoptotic cells (Figure 4a, left two panels). Thus,
an apoptotic response to 2-5A transfection distinguished
immortalized SV-WI38 cells from their parental
cells, and suggested that intrinsic cellular factors
can modulate the antiproliferative phenotype induced
by 2-5A.
Physiological impact of RNase-L on longevity
The proliferative capacity of primary cells in culture
inversely correlates with the in vivo age and lifespan
of the donor organism, and senescent cells accumulate
in aged tissues, providing evidence for senescence as an
in vitro model for organismal aging (Campisi, 2003).
To determine if the involvement of RNase-L in
cellular senescence resulted in an altered lifespan of
RNase-L / mice, aging colonies were established.
Specifically, 82 male RNase-L / mice and 98 strain-
matched male WT mice were housed in a pathogen-free
environment, and monitored for 152 weeks. To ensure
that our analysis reflected the natural lifespan of the
mice, animals that died from injury or disease were
censored in the study. Remarkably, Kaplan–Meier
analysis revealed a significant increase in the mean
survival time of RNase-L / mice (10875.6 weeks)
compared to WT mice (8274.6 weeks). The age at
which survival probability was 50% (T50), and the
maximum survival age (Tmax) were increased by 28 and
16%, respectively, in the RNase-L / mice. Thus, the
absence of RNase-L resulted in a significant 31.7%
(Po0.0001) increased lifespan as compared to the WT
mice (Figure 5 and Table S1), and suggests a novel role
for RNase-L in longevity.
Discussion
A functional role for RNase-L in replicative senescence
Endogenous constraints on cell proliferation represent
logical end points for therapeutic intervention in the
treatment of human malignancies. Accordingly,
much effort has focused on dissecting the molecular
components of antiproliferative pathways. Indeed, the
induction of apoptosis by chemotherapeutic agents
has been extensively studied, however, relatively
little is known about the senescent response and its
potential utility in cancer therapy (Schmitt, 2003;
Shay and Roninson, 2004). Recent studies have demon-
strated the presence of senescent cells in premalignant,
but not malignant, tumors providing evidence for
the tumor suppressive function of senescence in vivo
Figure 4 RNase L activation results in senescence and apoptosis
in primary and immortalized HDFs, respectively. (a) WI38 and SV
WI38 cells were transfected with 5 mM 2 5A tetramer for 90min;
apoptotic cells were labeled by TUNEL assay, and senescent cells
were stained for b gal activity. Light micrographs of typical fields
are shown, and the percentage of senescent and apoptotic cells was
determined by counting. (b) WI38 HDFs were transfected with
2 5A tetramer at the concentrations indicated for 90min, then
incubated with fresh medium and stained for b gal activity after
36 h; b gal positive cells were quantified by counting as indicated in
the graph.
Figure 3 Senescence is delayed in RNase L / MEFs. (a) RNase
L / and strain matched RNase Lþ /þ MEFs were cultured until
the RNase Lþ /þ MEFs began to exhibit a senescent phenotype
(PDLC10), and then stained for b gal activity; a light micrograph
of a typical field is shown. b gal positive cells were quantified by
counting replicate fields in three independent cultures, and the
mean was expressed as a percentage of the total cells counted.
(b) RNase L / and þ /þ MEFs were counted at each passage and
the PDL was determined.
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(Braig et al., 2005; Chen et al., 2005; Collado et al.,
2005; Michaloglou et al., 2005). The current challenge
is to identify the molecular mediators of senescence,
and determine how they are regulated in diverse
oncogenic settings. IFN and ISGs are implicated
in the senescent response (Kulaeva et al., 2003;
Xin et al., 2004), and RNase-L is an established
mediator of the antiproliferative activity of IFN (Hassel
et al., 1993; Zhou et al., 1997), and functions as a tumor
suppressor (Carpten et al., 2002; Casey et al., 2002);
therefore, we examined the potential role for RNase-L
in senescence.
Ectopic expression of RNase-L induced a prolifera-
tive arrest and a senescent phenotype in murine and
human cells (Figures 1–3). In vitro lifespan was reduced
in RNase-L overexpressing cells and increased in
RNase-L / cells (Figures 2 and 3), providing evidence
of a functional role for RNase-L in replicative
senescence. In addition, 2-5A transfection activated
RNase-L and resulted in telomere shortening, a hall-
mark of replicative senescence (data not shown). A
detectable increase in RNase-L was not observed in
senescent cells (data not shown), suggesting that small,
transient changes in RNase-L expression may be
sufficient to initiate the senescence program. OAS is
upregulated in senescence, and may function to activate
RNase-L-induced senescence in the absence of changes
in RNase-L expression (Kulaeva et al., 2003; Yoon
et al., 2004).
Activation of endogenous RNase-L induces senescent and
apoptotic responses
Cellular stresses including treatment with chemo-
therapeutic agents, oncogene activation, and oxidative
damage induce senescent or apoptotic responses de-
pending on the cell type and physiological context
(Schmitt, 2003; Shay and Roninson, 2004). 2-5A
transfection induces apoptosis in prostate cancer cell
lines, and this response was reduced in normal prostate
epithelia which may have reflected a senescent outcome
(Malathi et al., 2004). 2-5A treatment and RNase-L
activation are associated with cellular stress responses,
including inhibition of protein synthesis and the
activation of stress kinases, that may contribute to its
senescence-inducing activity (Iordanov et al., 2000; Li
et al., 2004). Remarkably, 2-5A transfection resulted in
an exclusively senescent response in WI38 HDFs, but
shifted to a more apoptotic response in immortalized
SV-WI38 cells. The transcription factors p53 and pRb
are critical mediators of senescence and apoptosis that
are inactivated by Large-T antigen in SV40-transformed
SV-WI38 cells (White and Khalili, 2004). The reduced
senescent response in SV-WI38 cells suggests that 2-5A-
induced senescence was mediated, in part, by p53 and
pRb transcriptional pathways. 2-5A mediated activation
of RNase-L is predicted to primarily impact messenger
RNA stability. However, a recent microarray analysis
reported that 2-5A transfection resulted in the induction
of more than twice as many genes as were repressed,
suggesting that the biological activities of RNase-L are
mediated by both RNA degradation and gene induction
(Malathi et al., 2005). A comparison of gene expression
in cells that exhibit senescent and apoptotic responses
to 2-5A will provide a better understanding of the
molecular basis of these outcomes.
RNase-L modulates aging in vivo
Cellular senescence functions as a tumor suppressor
mechanism by inducing a permanent growth arrest that
is associated with cellular aging in vitro and in vivo.
Indeed, the same genes that mediate senescence also
function in tumor suppression (Campisi, 2003; Shay and
Roninson, 2004), providing a mechanistic link between
cancer, long known to be an age-associated disease and
aging. Senescence-associated tumor suppressor genes,
designated ‘gatekeepers’, are thought to protect the
organism from cancer during its younger, reproductive
years, but to exhibit detrimental effects that contribute
to aging in older individuals (Campisi, 2003). Consistent
with this relationship between senescence, aging and
cancer, senescent cells are more prevalent in aged
tissues, and secrete growth factors and proteases
resulting in a pro-oncogenic environment (Campisi,
2003). As a tumor suppressor that functions in apoptosis
and senescence, RNase-L fits the definition of a
gatekeeper gene. In this capacity, genetic disruption of
RNase-L in mice is predicted to increase the in vivo
lifespan. In fact, RNase-L / mice survived 31.7%
longer than strain-matched WT mice (Figure 5,
Table S1) providing evidence for a physiological role
for RNase-L in aging. In agreement with this finding, an
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Figure 5 RNase L / mice exhibit enhanced longevity. Kaplan
Meier survival curve: C57BL/6 mice with a pure genetic back
ground of RNase Lþ /þ , n 98, and RNase L / , n 82 were
monitored for a period of 152 weeks and analysed for their survival
probability using product limit method of Kaplan and Meier as
described (Materials and methods). Solid and broken lines show
the survival of RNase L / and WT mice respectively. Data from
deaths due to infection or injury were not included in the study; the
deaths of individual mice are depicted as (I) in the graph, and this
data is provided in Supplementary Table S3. Tmax and T50 in
weeks are shown in the box insert.
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age-dependent increase in IFN-b and OAS in human
fibroblasts (Tahara et al., 1995), and in RNase-L from
mouse tissues was reported previously (Floyd-Smith and
Denton, 1988). Importantly, mice that died from injury
or disease were excluded from this study to insure the
analysis reflected a natural lifespan rather than an
increased susceptibility to disease associated with dele-
tion of the RNase-L gene. RNase-L / mice did not die
of tumors suggesting that other insults, in addition to
the loss of this tumor suppressor, are required for
tumorigenesis. Longevity is a complex phenotype that is
estimated to be 48–79% heritable in mice, and a number
of genes that impact lifespan have been identified
(Quarrie and Riabowol, 2004). The specific role of
RNase-L in aging and how it may impact other aging-
associated genes requires further investigation.
Tumor cells retain the capacity to undergo senescence,
thus inducers of senescence represent a new class of
tumor suppressor (Schmitt, 2003). Our results identify a
novel role for RNase-L in senescence that may
contribute to its tumor suppressive function, and to
the enhanced longevity of RNase-L / mice.
Materials and methods
Kaplan Meier survival analysis
RNase L / and strain matched RNase Lþ /þ mice were
housed in a pathogen free facility, and no difference was
observed in the growth or health of the RNase L / and þ /þ
mice (Zhou et al., 1997). The survival of RNase L / (n¼ 82)
and þ /þ (n¼ 98) mice was monitored for a period of 152
weeks. Mice that died from disease or injury were excluded
from the longevity study. The product limits method of
Kaplan and Meier (Kaplan EL, 1958) was used to estimate the
survival function S defined as:
S^ðtÞ ¼
Y
tipt
1
di
ni
 
where ti is duration of study at point i, di is number of deaths
up to point i and ni is number of individuals at risk just before
ti. S is the product (P) of these conditional probabilities.
Analysis was performed using SPSS 14.0 software (see
Supplementary data Tables S1 S3).
Cell culture
Embryos derived from RNase L / and strain and age
matched WT mice that had been backcrossed for 10
generations to C57/Bl6 mice were used to prepare primary
MEFs (Zhou et al., 1997). Cells were cultured at 371C in a
humidified chamber of 95% air, 5% CO2 and passaged twice a
week at a constant inoculum of 6.7 104 cells/cm2.
WI38 HDFs and SV40 immortalized WI38 cells (SV WI38;
Coriell Cell Repository, Camden, NJ, USA) were cultured in
minimum essential medium (Sigma, St Louis, MO, USA)
supplemented with 10% fetal bovine serum (FBS) (20% FBS
for SV WI38), 2mM L glutamine, 2 essential, non essential
amino acids and vitamin solution (Invitrogen, Carlsbad, CA,
USA). Cells were passaged twice a week at a constant
inoculum of 1.3 103 cells/cm2. Swiss 3T3 and NIH 3T3 cells
were cultured in Dulbecco’s modified Eagle’s medium supple
mented with 10% FBS, 2mM L glutamine and 1% antibiotic
antimycotic solution.
Retroviral vectors and gene transduction
The human RNase L complementary DNA (cDNA) contain
ing an amino terminus c myc epitope tag was cloned into the
retroviral vector, pBabe puro. pBabe RNase L or vector
control was transfected into the Bosc23 packaging cell line
using Lipofectamine plus as per the manufacturers instruc
tions (Invitrogen, Carlsbad, CA, USA) and virus containing
supernatants were collected. WI38 and SV WI38 cells were
infected with the pBabe RNase L, or pBabe virus and stable
cell lines were selected by growth in 3mg/ml puromycin.
Microinjection, [3H] thymidine labeling and immunostaining
Balb/c 3T3 cells were grown on coverslips until approximately
50% confluence. All cells contained within a circular field
inscribed on the coverslip were microinjected with the
pcDNA1 RNase L expression construct (pRNase L) or empty
vector as described (Smith et al., 1986). At 24 h post injection,
cells were labeled with 5mCi [3H] thymidine (Amersham,
Piscataway, NJ, USA) for an additional 18 h, then fixed
and immunostained for RNase L. The primary antibody to
human RNase L (Dong and Silverman, 1995) was used at a
1:1000 dilution in 0.5% bovine serum albumin/phosphate
buffered saline, and RNase L was visualized using the
secondary antibody, Cy3 conjugated donkey anti mouse im
munoglobulin G (Jackson ImmunoResearch Laboratories
Inc., West Grove, PA, USA) at a 1:2000 dilution. Air dried
coverslips were mounted on slides and autoradiography was
performed as described (Mulcahy et al., 1985). RNase L
immunostaining and nuclear labeling were visualized by
fluorescence and bright field microscopy, respectively, and
quantified by counting.
2 5A Transfection
Cells seeded at 7.5 103 cells/cm2 in a chamber slide were
transfected with tetramer 2 5A (p3A(2
0p50A)3) at the concen
trations indicated for 90min using Ca2þ phosphate. Cells were
then cultured for 36 h before staining for senescence or
apoptosis.
Senescence associated b gal staining
Cells were seeded at 3 104 cells/well in a 4 cm2 chamber slide
(Nalge Nunc, Naperville, IL, USA) 48 h before senescence
associated b gal staining according to manufacturer’s protocol
(Cell Signaling, Beverly, MA, USA). Cells which stained blue,
were considered positive for b Gal activity (Dimri et al., 1995).
Apoptosis staining (TUNEL assay)
Apoptotic cells were stained according to the manufacturer’s
protocol (Calbiochem, La Jolla, CA, USA). After labeling,
cells were immediately counterstained with methyl green
solution for detection of non apoptotic cells. Nuclei stained
black or green were considered apoptotic or non apoptotic,
respectively.
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